ASX:CSLPharmaceuticals, Biotechnology & Life SciencesBiotechnology
CSL Ltd
$115.390
+$0.520 (+0.45%)
Day Range
$112.400 – $116.500
52 Week Range
$90.000 – $275.790
Volume
1.46M
Avg Volume (10D)
2.65M
Market Cap
$55.26B
P/E Ratio
12.85
Price Chart
Market Statistics
Open$113.000
Previous Close$114.870
Day High$116.500
Day Low$112.400
52 Week High$275.790
52 Week Low$90.000
Valuation
Market Cap55.26B
Shares Outstanding478.91M
P/E Ratio (Annual)12.85
P/E Ratio (TTM)27.64
Dividend Yield2.60%
Price to Book2.05
Trading Activity
Volume1.46M
Value Traded168.09M
Bid$115.340 × 25
Ask$115.390 × 282
Performance
1 Day-2.36%
5 Day-1.25%
13 Week-19.78%
52 Week-52.13%
YTD-33.47%
Technical Indicators
RSI (14)60.94
50-Day SMA$110.128
200-Day SMA$157.838
Latest News
Hot Topics
Weekly Wrap: ASX 200 Slips On Resource Rout; BHP Hit By Potash Cost Overrun
ASX 200 dips 0.9% as BHP slides 5.6 on US$6.9b Jansen potash overrun; resources slump while healthcare jumps ~5%—defensives lift in this weekly wrap.
Hot Topics
SmallCaps Weekly Wrap & New Fundie Picks
Hot Topics
Weekly wrap: ASX loses steam amid hairy chested war rhetoric
ASX slips as Trump-Iran tension persists; IGO sinks 18% on lithium gloom, while energy stocks rally; weekly loss about 1.8%.
Hot Topics
Weekly Wrap: ASX investors pondering a heap of variables over Easter
ASX ends Easter week near 1% higher amid oil spikes and Trump-Iran tensions; energy trims losses while tech slides, awaiting post-holiday trading.